Table 2.
Serum and membrane lipids, patients and healthy controls, case–control and longitudinal data
| Patients T1 | Patients T2 | Healthy controls T1 | Healthy controls T2 | |
|---|---|---|---|---|
| n = 55 | n = 55 | n = 20 | n = 51 | |
| PUFA | 434 (171,507) | 471 (440,513)*** | 478 (446,495)*** | 470.0 (437,508) |
| LCPUFA | 283 (89,337) | 308 (291,334)*** | 307 (293,330)*** | 306 (287,336) |
| S-cholesterol | 5.00 ± 1.12 | 5.36 ± 1.20 | ¤ | 5.05 ± 0.84 |
| S-triglyceride | 1.50 (0.80,2.48)### | 1.33 (0.95,2.66)### | ¤ | 0.85 (0.59,1.12) |
*** P <0.001 vs. patients T1, ### P < 0.001 vs. healthy controls T2
¤not measured
Serum cholesterol: normally distributed, mean ± standard deviation
Serum triglyceride, PUFA, LCPUFA: non-normally distributed, median (25,75 percentiles)
Patients T1 vs patients T2: Wilcoxon signed rank test
Patients T1 and T2 vs healthy controls T1: Mann–Whitney test
Healthy control T1 vs healthy controls T2: Wilcoxon signed rank test
PUFA = omega-3 + omega-6 polyunsaturated fatty acids in red blood cells
LCPUFA = omega-3 + omega-6 PUFA with 20 or more carbon atoms in red blood cells